8-chloroadenosine has been researched along with Adenocarcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| An, GS; Cai, WW; Cao, JX; Duan, HY; Jia, HT; Li, SY; Ni, JH; Qi, JJ; Wu, GS | 1 |
| Taylor, CW; Yeoman, LC | 1 |
2 other study(ies) available for 8-chloroadenosine and Adenocarcinoma
| Article | Year |
|---|---|
E2F1 enhances 8-chloro-adenosine-induced G2/M arrest and apoptosis in A549 and H1299 lung cancer cells.
Topics: 2-Chloroadenosine; Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; DNA Damage; E2F1 Transcription Factor; G2 Phase Cell Cycle Checkpoints; Humans; Lung Neoplasms; M Phase Cell Cycle Checkpoints | 2012 |
Inhibition of colon tumor cell growth by 8-chloro-cAMP is dependent upon its conversion to 8-chloro-adenosine.
Topics: 2-Chloroadenosine; 8-Bromo Cyclic Adenosine Monophosphate; Adenocarcinoma; Biotransformation; Blood; Cell Division; Chromatography, High Pressure Liquid; Colonic Neoplasms; Culture Media; Drug Resistance; Drug Screening Assays, Antitumor; Humans; Prodrugs; Tumor Cells, Cultured | 1992 |